期刊
AMERICAN JOURNAL OF NEURORADIOLOGY
卷 41, 期 6, 页码 1015-1021出版社
AMER SOC NEURORADIOLOGY
DOI: 10.3174/ajnr.A6575
关键词
-
资金
- NutsOhra (FNO grant) from the NutsOhra Fund [1403-023]
BACKGROUND AND PURPOSE: In patients with SAH, the amount of blood is strongly associated with clinical outcome. However, it is commonly estimated with a coarse grading scale, potentially limiting its predictive value. Therefore, we aimed to develop and externally validate prediction models for clinical outcome, including quantified blood volumes, as candidate predictors. MATERIALS AND METHODS: Clinical and radiologic candidate predictors were included in a logistic regression model. Unfavorable outcome was defined as a modified Rankin Scale score of 4?6. An automatic hemorrhage-quantification algorithm calculated the total blood volume. Blood was manually classified as cisternal, intraventricular, or intraparenchymal. The model was selected with bootstrapped backward selection and validated with the R-2, C-statistic, and calibration plots. If total blood volume remained in the final model, its performance was compared with models including location-specific blood volumes or the modified Fisher scale. RESULTS: The total blood volume, neurologic condition, age, aneurysm size, and history of cardiovascular disease remained in the final models after selection. The externally validated predictive accuracy and discriminative power were high (R-2 = 56% ? 1.8%; mean C-statistic = 0.89 ? 0.01). The location-specific volume models showed a similar performance (R-2 = 56% ? 1%, P?=?.8; mean C-statistic = 0.89 ? 0.00, P?=?.4). The modified Fisher models were significantly less accurate (R-2 = 45% ? 3%, P < .001; mean C-statistic = 0.85 ? 0.01, P?=?.03). CONCLUSIONS: The total blood volume?based prediction model for clinical outcome in patients with SAH showed a high predictive accuracy, higher than a prediction model including the commonly used modified Fisher scale.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据